Latest Oncotype DX Stories
The Diagnostics Marketing Association (DxMA) hosted their annual Global Marketing Summit and Dx Creative Communications Awards Ceremony last month in San Francisco, CA.
13% Increase in Test Volume and 7% Increase in Product Revenue Compared to Prior Year REDWOOD CITY, Calif., May 6, 2014 /PRNewswire/ -- Genomic Health, Inc.
New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/
Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc.
REDWOOD CITY, Calif., April 29, 2014 /PRNewswire/ -- Genomic Health, Inc.
Expanded Reimbursement in Canada and Inclusion in Leading German Physician Guidelines Increase Genomic Health's Impact in Key International Markets REDWOOD CITY, Calif., April 22,
Data Presented at 9th European Breast Cancer (EBCC-9) Symposium Highlights Comprehensive Body of Clinical Evidence for Oncotype DX REDWOOD CITY, Calif., March 19, 2014 /PRNewswire/ -- Genomic
Genomic Health Successfully Launched a Viral Educational Concept for Reaching People Touched by Breast Cancer Titled “Pass It On, Until Every Woman Knows” Indianapolis,
15% Increase in Full-Year Test Volume; 21% Increase in 4th Quarter Test Volume REDWOOD CITY, Calif., Feb. 4, 2014 /PRNewswire/ -- Genomic Health, Inc.
New data show real-life impact of Oncotype DX on treatment decisions, underscore clinical validity and utility of the test REDWOOD CITY, Calif., Jan.
- The abrogation of a law by a higher authority; annulment.